Pharmaceutical composition comprising hyaluronic acid and stem cells for the treatment of diseases associated with cartilage damage
KR20200034331A
A composition for activating a skin cell and uses thereof
KR20160108190A
Pharmaceutical composition for the prevention or treatment of a lung disease comprising mesenchymal stem cells having improved proliferation and differentiation capacity
KR20160143837A
An Ability of Conditioned Media of stimulated Stem cells for Hair-growth and the Use thereof
EP3146973A1
Hair growth-promoting function of small-sized stem cells and use thereof
KR20150141812A
An Whitening Ability of Small-Sized Stem Cells and the Use thereof
KR20150028052A
Method for culturing mesenchymal stem cells according to cell size
US2014303087A1
Treating cartilage defect with UCB-MSC expressing TSP-2
KR20140089743A
Dispenser
AU2012258424A1
Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
KR20140038236A
Method for preparing mesenchymal stem cell aggregates
KR20140030703A
Method for culturing mesenchymal stem cells
AU2012216643A1
Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs
KR20130143423A
Syringe pump
CA2825641A1
Use of icam-1 for prevention or treatment of neurological diseases
KR20100119532A
COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-α, COMPRISING UCB-MSCS
KR20100122877A
Mesenchymal stem cell derived from umbilical cord blood expressing tenascin-c and use thereof
BRPI1015225A2
methods of identifying the ability of a stem cell to differentiate a cell into a chondrocyte, to differentiate ce = cell into a chondrocyte and to stem cell into a lesion tissue cell, to decrease chondrocyte death, to increase expression of at least a protein selected from the group consisting of tsp-2 and hb-egf from stem cell, sorting material that regulates stem cell activity and increasing expression of at least one selected from the group consisting of tsp -2 and hb-egf from stem cell and compositions for stimulating a cell to differentiate into a chondrocyte and to decrease chondrocyte death
MY153917A
Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
